Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Evolution of percutaneous coronary intervention in patients with diabetes: a report from the National Heart, Lung, and Blood Institute-sponsored PTCA (1985-1986) and Dynamic (1997-2006) Registries.

Rana JS, Venkitachalam L, Selzer F, Mulukutla SR, Marroquin OC, Laskey WK, Holper EM, Srinivas VS, Kip KE, Kelsey SF, Nesto RW; NHLBI-sponsored PTCA and Dynamic Registries Investigators.

Diabetes Care. 2010 Sep;33(9):1976-82. doi: 10.2337/dc10-0247. Epub 2010 Jun 2.

2.

Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry).

Parikh SV, Saya S, Divanji P, Banerjee S, Selzer F, Abbott JD, Naidu SS, Wilensky RL, Faxon DP, Jacobs AK, Holper EM.

Am J Cardiol. 2011 Apr 1;107(7):959-64. doi: 10.1016/j.amjcard.2010.11.019. Epub 2011 Jan 20.

3.

Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.

Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE.

JACC Cardiovasc Interv. 2008 Apr;1(2):139-47. doi: 10.1016/j.jcin.2008.02.005.

4.

Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.

Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF; Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries.

Circ Cardiovasc Interv. 2009 Feb;2(1):6-13. doi: 10.1161/CIRCINTERVENTIONS.108.825323. Epub 2008 Dec 15.

5.

Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.

Parikh SV, Luna M, Selzer F, Marroquin OC, Mulukutla SR, Abbott JD, Holper EM.

Catheter Cardiovasc Interv. 2014 Feb;83(2):192-200. doi: 10.1002/ccd.23194. Epub 2013 Oct 24.

6.

Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.

Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO.

J Am Coll Cardiol. 2007 Nov 20;50(21):2029-36.

7.

Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry.

Bangalore S, Vlachos HA, Selzer F, Wilensky RL, Kip KE, Williams DO, Faxon DP.

Catheter Cardiovasc Interv. 2011 Jan 1;77(1):22-8. doi: 10.1002/ccd.22613.

8.

Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.

Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.

Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578.

9.

One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).

Mieres J, Fernandez-Pereira C, Risau G, Solorzano L, Pauletto R, Rodriguez-Granillo AM, Rubilar B, Stella P, Rodriguez AE.

Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):265-71. doi: 10.1016/j.carrev.2012.06.001. Epub 2012 Jul 15.

PMID:
22796496
10.

Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic Registry.

Olafiranye O, Vlachos H, Mulukutla SR, Marroquin OC, Selzer F, Kelsey SF, Williams DO, Strollo PJ, Reis SE, Lee JS, Smith AJ.

Int J Cardiol. 2015 Apr 1;184:79-85. doi: 10.1016/j.ijcard.2015.01.071. Epub 2015 Jan 27.

11.

Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).

Bainey KR, Selzer F, Cohen HA, Marroquin OC, Holper EM, Graham MM, Williams DO, Faxon DP.

Am J Cardiol. 2012 Jan 15;109(2):195-201. doi: 10.1016/j.amjcard.2011.08.028. Epub 2011 Oct 14.

12.

Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry.

Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, Sedrakyan A, Booth ME, Douglas PS, Messenger JC.

Catheter Cardiovasc Interv. 2014 Feb;83(2):171-81. doi: 10.1002/ccd.25108. Epub 2013 Aug 31. Erratum in: Catheter Cardiovasc Interv. 2014 Jul 1;84(1):168. Sedrakayan, Art [corrected to Sedrakyan].

PMID:
23907981
13.

Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.

Onuma Y, Kukreja N, Daemen J, Garcia-Garcia HM, Gonzalo N, Cheng JM, van Twisk PH, van Domburg R, Serruys PW; Interventional Cardiologists of Thoraxcenter.

JACC Cardiovasc Interv. 2009 Jul;2(7):603-10. doi: 10.1016/j.jcin.2009.03.016.

14.

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.

Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF; EVENT Investigators.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

PMID:
22431166
15.
16.

Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008.

Patel MR, Marso SP, Dai D, Anstrom KJ, Shunk KA, Curtus JP, Brennan JM, Sedrakyan A, Messenger JC, Douglas PS.

JACC Cardiovasc Interv. 2012 Oct;5(10):1054-61. doi: 10.1016/j.jcin.2012.05.017.

17.

Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.

Assali A, Vaduganathan M, Vaknin-Assa H, Lev EI, Brosh D, Teplitsky I, Bental T, Battler A, Kornowski R.

Am J Cardiol. 2012 Jun 1;109(11):1563-8. doi: 10.1016/j.amjcard.2012.01.378. Epub 2012 Mar 20.

PMID:
22440117
19.

Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.

Luo Y, Yu X, Chen F, Du X, He J, Gao Y, Zhang X, Zhang Y, Ren X, Lv S, Ma C.

Coron Artery Dis. 2012 Aug;23(5):322-9. doi: 10.1097/MCA.0b013e3283564961.

PMID:
22750912
20.

Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group.

Brodie BR, Stuckey T, Downey W, Humphrey A, Nussbaum M, Laurent S, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA; Strategic Transcatheter Evaluation of New Therapies (STENT) Group.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):893-900. doi: 10.1002/ccd.21767.

PMID:
19016465

Supplemental Content

Support Center